Global Vagal Nerve Stimulation (VNS) Market 2022-2028

July 2022 | 67 pages | ID: G453FBF4A98EEN
Gen Consulting Company

Abstracts

Vagus nerve stimulation (VNS) involves the use of a device to stimulate the vagus nerve with electrical impulses. VNS may be an option to reduce the frequency of seizures in people who haven't achieved control with medications. Vagus nerve stimulation may also be helpful for people who haven't responded to intensive depression treatments, such as antidepressant medications, psychological counseling (psychotherapy) and electroconvulsive therapy (ECT). According to Gen Consulting Company, the global vagal nerve stimulation market is set to achieve an incremental growth of USD 420 million, acelerating at a CAGR of almost 9.8% during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global vagal nerve stimulation market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the vagal nerve stimulation industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for vagal nerve stimulation can be segmented by product: external VNS devices, implantable VNS devices. Among these, the implantable VNS devices segment was accounted for the highest revenue generator in 2021. Vagal nerve stimulation market is further segmented by application: depression, epilepsy, others. The epilepsy segment is estimated to account for the largest share of the global vagal nerve stimulation market. Based on end user, the vagal nerve stimulation market is segmented into: ambulatory surgical centers (ASCs), hospitals, others. On the basis of region, the vagal nerve stimulation market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By product:

• external VNS devices
• implantable VNS devices

By application:

• depression
• epilepsy
• others

By end user:

• ambulatory surgical centers (ASCs)
• hospitals
• others

By region:

• North America
• Asia Pacific
• Europe
• Rest of the World (ROW)

The diagnosis market is further segmented into computed tomography (CT), magnetic Resonance Imaging (MRI), others. The CT segment captured the largest share of the market in 2021 and is expected to maintain its dominance during the forecast period. Furthermore, the treatment market has been categorized into medication, surgery. According to the research, the medication segment had the largest share in the global vagal nerve stimulation market.

The market research report covers the analysis of key stake holders of the global vagal nerve stimulation market. Some of the leading players profiled in the report include Boston Scientific Corporation, electroCore, Inc., ImThera Medical, Inc. (LivaNova PLC), Innovative Health Solutions, Inc, Inspire Medical Systems Inc, NeuroMetrix, Inc., Parasym Ltd, ReShape Lifesciences Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global vagal nerve stimulation market.
• To classify and forecast the global vagal nerve stimulation market based on product, application, end user, region.
• To identify drivers and challenges for the global vagal nerve stimulation market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global vagal nerve stimulation market.
• To identify and analyze the profile of leading players operating in the global vagal nerve stimulation market.

Why Choose This Report

• Gain a reliable outlook of the global vagal nerve stimulation market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

External VNS devices
Implantable VNS devices

PART 6. MARKET BREAKDOWN BY APPLICATION

Depression
Epilepsy
Others

PART 7. MARKET BREAKDOWN BY END USER

Ambulatory surgical centers (ASCs)
Hospitals
Others

PART 8. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 9. KEY COMPANIES

Boston Scientific Corporation
electroCore, Inc.
ImThera Medical, Inc. (LivaNova PLC)
Innovative Health Solutions, Inc
Inspire Medical Systems Inc
NeuroMetrix, Inc.
Parasym Ltd
ReShape Lifesciences Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER